Pamala A. Jacobson

3.9k total citations
131 papers, 2.6k citations indexed

About

Pamala A. Jacobson is a scholar working on Transplantation, Hematology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Pamala A. Jacobson has authored 131 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 69 papers in Transplantation, 39 papers in Hematology and 31 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Pamala A. Jacobson's work include Renal Transplantation Outcomes and Treatments (68 papers), Hematopoietic Stem Cell Transplantation (36 papers) and Pharmacogenetics and Drug Metabolism (20 papers). Pamala A. Jacobson is often cited by papers focused on Renal Transplantation Outcomes and Treatments (68 papers), Hematopoietic Stem Cell Transplantation (36 papers) and Pharmacogenetics and Drug Metabolism (20 papers). Pamala A. Jacobson collaborates with scholars based in United States, Egypt and United Kingdom. Pamala A. Jacobson's co-authors include Ajay K. Israni, William S. Oetting, Arthur J. Matas, Rory P. Remmel, Richard C. Brundage, Robert Leduc, Weihua Guan, David Schladt, Roslyn B. Mannon and W. Guan and has published in prestigious journals such as Nature Medicine, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Pamala A. Jacobson

125 papers receiving 2.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Pamala A. Jacobson United States	29	1.4k	752	571	419	400	131	2.6k
Éric Thervet France	28	1.8k 1.3×	1.1k 1.5×	148 0.3×	569 1.4×	332 0.8×	62	3.4k
Stein Bergan Norway	26	1.1k 0.8×	653 0.9×	125 0.2×	469 1.1×	284 0.7×	106	2.1k
Maria Shipkova Germany	40	3.2k 2.3×	1.0k 1.3×	321 0.6×	760 1.8×	603 1.5×	123	5.0k
Jean‐Baptiste Woillard France	28	1.0k 0.7×	619 0.8×	81 0.1×	367 0.9×	372 0.9×	125	2.1k
Stephen J. Tomlanovich United States	30	1.8k 1.3×	463 0.6×	106 0.2×	1.2k 2.8×	235 0.6×	48	3.4k
Bruno Hurault de Ligny France	30	1.6k 1.1×	288 0.4×	191 0.3×	836 2.0×	212 0.5×	122	3.4k
Vijay Warty United States	27	1.2k 0.9×	821 1.1×	95 0.2×	1.0k 2.5×	313 0.8×	77	3.0k
Yingyos Avihingsanon Thailand	31	499 0.4×	194 0.3×	150 0.3×	360 0.9×	270 0.7×	159	2.9k
Maarten H. L. Christiaans Netherlands	43	3.0k 2.1×	844 1.1×	137 0.2×	1.9k 4.6×	234 0.6×	148	4.6k
Reginald Gohh United States	25	512 0.4×	250 0.3×	119 0.2×	451 1.1×	177 0.4×	102	1.6k

Countries citing papers authored by Pamala A. Jacobson

Since Specialization

Citations

This map shows the geographic impact of Pamala A. Jacobson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pamala A. Jacobson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pamala A. Jacobson more than expected).

Fields of papers citing papers by Pamala A. Jacobson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pamala A. Jacobson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pamala A. Jacobson. The network helps show where Pamala A. Jacobson may publish in the future.

Co-authorship network of co-authors of Pamala A. Jacobson

This figure shows the co-authorship network connecting the top 25 collaborators of Pamala A. Jacobson. A scholar is included among the top collaborators of Pamala A. Jacobson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pamala A. Jacobson. Pamala A. Jacobson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Jacobson, Pamala A., Jeffrey R. Bishop, Natasha Petry, et al.. (2025). Pharmacogenomics case-based education: Establishment of an Extension for Community Health Outcomes (ECHO) education model for healthcare professionals. American Journal of Health-System Pharmacy. 83(2). 102–112.

Shen, Cheng, et al.. (2025). Microbiome‐Informed Dosing: Exploring Gut Microbial Communities Impact on Mycophenolate Enterohepatic Circulation and Therapeutic Target Achievement. Clinical Pharmacology & Therapeutics. 118(6). 1477–1488.

Long, Susan E., et al.. (2025). CYP2B6 genetic variation in cyclophosphamide metabolism and hemorrhagic cystitis in Fanconi anemia patients undergoing allogeneic hematopoietic cell transplantation: A descriptive genetic association study. Medicine. 104(12). e41937–e41937.

Gao, Hui, Bao‐Li Loza, Sarah Gao, et al.. (2024). Assessing the Utility of a Genotype‐Guided Tacrolimus Equation in African American Kidney Transplant Recipients: A Single Institution Retrospective Study. The Journal of Clinical Pharmacology. 64(8). 944–952. 1 indexed citations

Al‐Kofahi, Mahmoud, Casey R. Dorr, Rory P. Remmel, et al.. (2024). Steroid–tacrolimus drug–drug interaction and the effect of CYP3A genotypes. British Journal of Clinical Pharmacology. 90(11). 2837–2848. 1 indexed citations

Khan, Mohammad H., Armin Rashidi, Shernan G. Holtan, et al.. (2022). Fecal β-glucuronidase activity differs between hematopoietic cell and kidney transplantation and a possible mechanism for disparate dose requirements. Gut Microbes. 14(1). 2108279–2108279. 11 indexed citations

Shaked, Abraham, Bao‐Li Loza, Elisabet Van Loon, et al.. (2022). Donor and recipient polygenic risk scores influence the risk of post-transplant diabetes. Nature Medicine. 28(5). 999–1005. 27 indexed citations

Jacobson, Pamala A., et al.. (2022). Knowledge and Attitudes of Incoming Pharmacy Students Toward Pharmacogenomics and Survey Reliability. Pharmacogenomics. 23(16). 873–885. 3 indexed citations

Brown, Jacob T., et al.. (2022). Perceptions of pharmacogenetic exceptionalism and the implications for clinical management within an electronic health record. Clinical and Translational Science. 15(9). 2265–2274. 1 indexed citations

10.

Al‐Kofahi, Mahmoud, Daniel J. Weisdorf, Claudio G. Brunstein, et al.. (2022). Comparison of Dose Adjustment Strategies for Obesity in High-dose Cyclophosphamide Among Adult Hematopoietic Cell Transplantation Recipients: Pharmacokinetic Analysis. Transplantation and Cellular Therapy. 28(12). 845.e1–845.e8. 1 indexed citations

11.

Schladt, David P., Baolin Wu, Weihua Guan, et al.. (2022). Higher number of tacrolimus dose adjustments in kidney transplant recipients who are extensive and intermediate CYP3A5 metabolizers. Clinical Transplantation. 37(4). e14893–e14893. 6 indexed citations

12.

Smith, Angela R., et al.. (2021). CYP2C19 Phenotype and Body Weight-Guided Voriconazole Initial Dose in Infants and Children after Hematopoietic Cell Transplantation. Antimicrobial Agents and Chemotherapy. 65(9). e0062321–e0062321. 22 indexed citations

13.

Luzum, Jasmine A., et al.. (2020). Pharmacogenomics of COVID-19 therapies. npj Genomic Medicine. 5(1). 35–35. 44 indexed citations

14.

Nguyen, Tam T. T. N., David P. Schladt, Danielle Berglund, et al.. (2020). Pharmacogenomics in kidney transplant recipients and potential for integration into practice. Journal of Clinical Pharmacy and Therapeutics. 45(6). 1457–1465. 6 indexed citations

15.

Smith, Angela R., et al.. (2020). Impact of Obesity on Voriconazole Pharmacokinetics among Pediatric Hematopoietic Cell Transplant Recipients. Antimicrobial Agents and Chemotherapy. 64(12). 8 indexed citations

16.

Oetting, William S., David P. Schladt, Casey R. Dorr, et al.. (2019). Analysis of 75 Candidate SNPs Associated With Acute Rejection in Kidney Transplant Recipients: Validation of rs2910164 in MicroRNA MIR146A. Transplantation. 103(8). 1591–1602. 14 indexed citations

17.

Sanghavi, Kinjal, Richard C. Brundage, Michael B. Miller, et al.. (2015). Genotype-guided tacrolimus dosing in African-American kidney transplant recipients. The Pharmacogenomics Journal. 17(1). 61–68. 59 indexed citations

18.

Pulk, Rebecca, David P. Schladt, William S. Oetting, et al.. (2015). Multigene Predictors of Tacrolimus Exposure in Kidney Transplant Recipients. Pharmacogenomics. 16(8). 841–854. 29 indexed citations

19.

Johnson, L’Aurelle A., Bhaskar Malayappan, Natalia Tretyakova, et al.. (2011). Formation of cyclophosphamide specific DNA adducts in hematological diseases. Pediatric Blood & Cancer. 58(5). 708–714. 33 indexed citations

20.

Jacobson, Pamala A., et al.. (2008). Higher Mycophenolate Dose Requirements in Children Undergoing Hematopoietic Cell Transplant (HCT). The Journal of Clinical Pharmacology. 48(4). 485–494. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact